에 대한 최신 뉴스 BloomZ (NASDAQ:BLMZ) 주식

BloomZ

BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.

BloomZ Inc

WIIM

AXIL

AXIL Brands shares are trading higher. The company reported Q1 financial results.

GAUZ

Gauzy shares are trading higher after the company announced its advanced driver assistance system (ADAS) will fully replace the traditional side mirrors for the buses of the Capital District Transportation Authority of New York. The company estimates cumulative revenue for its commercial camera monitor system (CMS) ADAS will surpass $100 million by the end of 2025.

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk has dreamed for years of having vehicles that don't require a driver and can take a passenger from one place to another. On Thursday, Musk's vision could be realized with the likely unveiling of <a href="https://www.benzinga.com/trading-ideas/24/10/41274987/how-to-watch-tesla-robotaxi-day-live-elon-musks-autonomous-vehicle-event-is-here">the Tesla Robotaxi.</a>
However, a new survey finds that when it comes to demand and consumer trust, the robot axis might not be ready for mass adoption.
What Happened: A new J.D. Power survey of consumers tests the experience and ratings of passengers who have taken a ride in <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41212796/tesla-robotaxi-day-preview-move-over-autonomous-vehicles-analyst-says-this-positive">an autonomous vehicle.</a>
The 2024 U.S. Robotaxi Experience Study <a href="https://www.jdpower.com/business/press-releases/2024-us-robotaxi-experience-study">found </a>that consumers had an average level of satisfaction of 8.53 on a 10-point scale.
The study, which took place in August, is based on the five categories of comfort and convenience, initiating the ride, riding in the vehicle, service availability and cost, and vehicle technology. Of the five categories, technology scored the highest.
Consumers who rode in a robotaxi had a 76% consumer confidence score for a fully automated, self-driving vehicle. While that score is relatively high, the consumer confidence score of people for fully automated, self-driving vehicles who have not ridden in a robotaxi was only 20%.
When asked to describe their ideal robotaxi service, respondents prioritized safety, with 78% selecting it as the most important factor, followed by reliability at 71% and trustworthiness at 66%.
One of the most important consumer requests in the survey was for the robotaxi to offer an emergency button to connect to local emergency services. Other requests were for the ability to select vehicles based on safety features and having the route set beforehand.
Companies mentioned in the report, which had their vehicles tested, include:
<ul>
<li>Cruise, which is majority owned by General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>)</li>
<li>May Mobility</li>
<li>Motional, which is a joint venture between Hyundai (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HYMLF#OTC">HYMLF</a>) and Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>)</li>
<li>Waymo, a subsidiary of Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)</li>
<li>Zoox, a subsidiary of Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</li>
</ul>
The study occurred in the five markets of Dallas, Las Vegas, Los Angeles, Phoenix and San Francisco.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Why It's Important: The study finds relatively high trust and satisfaction ratings for consumers who experience a robotaxi in some of the largest cities that have approved or are testing the technology.
Another takeaway from the report is that even living in a city with robotaxis and higher consumer awareness can improve trust in the technology. The study found that consumer confidence was 34% for people who had not ridden in a robotaxi and lived in one of the cities with robotaxis in operation.
"The robotaxi segment is still anyone's game, given that most people are not familiar with robotaxi brands and haven't formed a clear associative imagery," J.D. Power Senior Director of user experience benchmarking and technology Kathleen Rizk said.
Rizk added that the companies with robotaxis need to "look beyond their deployment markets and find ways to educate and build trust with all consumers."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/education/24/10/41166723/how-many-evs-has-tesla-delivered-produced-each-quarter-a-look-at-the-results-since-2019" target="_blank" rel="noreferrer noopener">How Many EVs Has Tesla Delivered, Produced Each Quarter? A Look At The Results Since 2019</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Tech

Trading Ideas

AMZN

APTV

GOOG

GOOGL

HYMLF

TLSA

TSLA

Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building

BNGO

Bionano Genomics shares are trading lower after the company cut its preliminary Q3 revenue guidance.

JP Morgan analyst Jimmy Bhullar maintains Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) with a Overweight and raises the price target from $205 to $207.

News

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Allstate, Raises Price Target to $207

SPCB

SuperCom shares are trading higher after the company announced it and its partner were awarded a 5-year national electronic monitoring contract with the Israel Prison Service Agency.

Editor's Note: Today you're getting a sneak peek at "Under The Radar" – a weekly email showcasing profit opportunities no one else is talking about, exclusive to members of Benzinga Edge. To get "Under The Radar" in your inbox every Tuesday, as well as a slew of other trade ideas, analysis, and investing tools, <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9spmirebz65&amp;utm_source=RD-1010">join Benzinga Edge here</a>.
There are lots of stories and discussions about insider buying that hit the internet every day. Most appear to have been written by people whose research into corporate insiders&#8217; buying and selling activities involves reading the book jacket blurbs on a book containing a chapter on insider activity.
Some insider buying matters. Some carry very little helpful information.
Although you will see breathless stories suggesting a likely stock market apocalypse because an insider is selling shares of a current market darling, the truth is that such sales are almost always meaningless.
A large institution buying more small company shares will often appear on the tape as a big insider buy. Still, this information is useless as an indicator of future returns.
Most option exercises and stock grants are worthless in terms of predictive value.
Knowing which insider purchases contain valuable information is critical if you use insider activity as a basis for investment or trading activities.
See, there's one group of insiders that consistently win when they open their checkbooks and buy their company&#8217;s stock on the open market.
Here's how to find them.
I am talking about C-suite executives. These are the folks involved in the big decisions about the company who want to see the daily operations and results.
They have a significant information advantage, not just over the public but also over other executives and board members.
The higher up on the food chain you are, the better your chances of making big money on your insider trades. The CEO and CFO have the highest probability of success.
Of these two, the CEO does not have the edge. The CEO sees everything that happens as planned for the company. The CFO lives with the numbers and cash flows all day, every day, and understands how every decision will impact the company&#8217;s profits and financial conditions.
Historically, that edge has allowed the CFO to earn very high returns when they make an open market purchase of their company stock.
Here at Under the Radar, we have spent considerable time reading studies and crunching data related to insider activity. One of the biggest lessons is that intelligent investors pay attention when a CFO whips out their checkbook.
The stock market has been very strong this year, so there has been far more insider selling than buying activity.
Insiders tend to be bargain hunters, and bargains have been hard to find recently.
Recently, we have seen two CFO buys that are worth our attention.
CFO Andrew Williams of Epsilon Energy (EPSN) has recently been making open-market six-figure purchases of his company.
While he bought his shares a little below the current market price, the low level of oil and gas in the third quarter is likely to lead to an earnings disappointment when the company reports its third-quarter results.
Epsilon is positioned to see a huge long-term profit increase due to increased natural gas demand over the next several years.
Recently, the CFO had done some financial modeling and understands, as we do, that the impact of rising natural gas prices on Epsilon&#8217;s bottom line should result in a dramatically higher stock price.
While the real opportunity in shares of Epsilon is the potential for several times your purchase price over the next several years, it doesn&#8217;t hurt that the company pays a generous dividend.
At the current price, Epsilon shares are yielding over 4%.
I know nothing about biotechnology or pharmaceutical development; I doubt that most Experts on the Internet have much knowledge of the drug approval process and which drugs will hit and which ones will not.
However, the C-suite executives have a pretty good idea of how it all works and the potential for their stock if they gain approval or cut a deal with a bigger company.
More than anyone, the CFO knows exactly what will happen to the bottom line in the case of these wildly positive developments.
When the Chief Financial Officer decides it is worth investing six figures in the stock of the company they oversee, it is worth paying attention.
Relmada Therapeutics Inc. (RLMD) is developing new drugs to treat central nervous system diseases. The company is also researching ways to use low-dose psilocybin as a treatment for metabolic diseases and is conducting other drug trials.
My knowledge of psilocybin as a treatment for anything is limited to a handful of Grateful Dead concerts in the 1970s.
CFO Maged Shenouda knows more about the drugs the company is developing and what it will do for the bottom line and stock price than I ever will.
He has been making open market purchases of the stock regularly this year, with the latest six-figure open market buys taking place just a few weeks ago.
He is not the only one buying. CEO Sergio is also making consistent large purchases of the stock.
Here is where it gets interesting.
Without much fanfare, Jefferies, the brokerage and research firm, recently upgraded the stock to a buy, saying that the current drug in Phase 3 trials has a chance of being a huge success for the company. Analyst Andrew Tsai raised his price target to $14.
Both stocks have remained under the radar of Main Street media and most of Wall Street.
If the CFOs are correct, both stocks have the potential for returns that are several times the current stock price.
Every Tuesday, Benzinga Edge members get a weekly "Under The Radar" story like this one, in addition to other trade ideas, investment analysis, and much more throughout the week. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9spmirebz65&amp;utm_source=RD-1010">Join Benzinga Edge here.</a>
Image Created Using Midjourney

Opinion

How To Find The Insider Trades That Consistently Outperform The Market – Under The Radar

Investors with a lot of money to spend have taken a bullish stance on Cleanspark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CLSK, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Cleanspark.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 25%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $211,500, and 6 are calls, for a total amount of $500,495.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $6.0 to $25.0 for Cleanspark over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Cleanspark's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cleanspark's whale activity within a strike price range from $6.0 to $25.0 in the last 30 days. 
<h3>Cleanspark 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728587031_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CLSK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$20.00</td>
<td>$288.9K</td>
<td>10.2K</td>
<td>997</td>
</tr>
<tr>
<td>CLSK</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$17.25</td>
<td>$16.8</td>
<td>$17.25</td>
<td>$25.00</td>
<td>$172.5K</td>
<td>2.5K</td>
<td>451</td>
</tr>
<tr>
<td>CLSK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/25/24</td>
<td>$0.26</td>
<td>$0.24</td>
<td>$0.25</td>
<td>$10.00</td>
<td>$74.6K</td>
<td>1.5K</td>
<td>3.1K</td>
</tr>
<tr>
<td>CLSK</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$2.08</td>
<td>$2.01</td>
<td>$2.05</td>
<td>$9.00</td>
<td>$40.9K</td>
<td>3.7K</td>
<td>225</td>
</tr>
<tr>
<td>CLSK</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$2.61</td>
<td>$2.59</td>
<td>$2.6</td>
<td>$10.00</td>
<td>$39.0K</td>
<td>3.2K</td>
<td>227</td>
</tr>
</tbody>
</table>

<h3>About Cleanspark</h3>
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.
After a thorough review of the options trading surrounding Cleanspark, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Cleanspark</h3>
<ul>
<li>With a trading volume of 9,485,958, the price of CLSK is down by -2.16%, reaching $8.67.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 50 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Cleanspark</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $24.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from HC Wainwright &amp; Co. has revised its rating downward to Buy, adjusting the price target to $27. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $23. 
&#x2A; Reflecting concerns, an analyst from HC Wainwright &amp; Co. lowers its rating to Buy with a new price target of $27. 
&#x2A; An analyst from Macquarie has revised its rating downward to Outperform, adjusting the price target to $20. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cleanspark options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

CLSK

A Closer Look at Cleanspark's Options Market Dynamics

Investors with a lot of money to spend have taken a bullish stance on General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 14 uncommon options trades for General Motors.
This isn't normal.
The overall sentiment of these big-money traders is split between 42% bullish and 42%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $243,598, and 11 are calls, for a total amount of $1,764,752.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $60.0 for General Motors over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for General Motors options trades today is 7054.08 with a total volume of 15,545.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for General Motors's big money trades within a strike price range of $30.0 to $60.0 over the last 30 days.
<h3>General Motors Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728587026_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.86</td>
<td>$1.67</td>
<td>$1.74</td>
<td>$60.00</td>
<td>$870.0K</td>
<td>18.1K</td>
<td>5.0K</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$0.89</td>
<td>$0.85</td>
<td>$0.87</td>
<td>$48.00</td>
<td>$174.0K</td>
<td>7.1K</td>
<td>2.0K</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.51</td>
<td>$1.46</td>
<td>$1.47</td>
<td>$47.00</td>
<td>$147.0K</td>
<td>10.8K</td>
<td>1.0K</td>
</tr>
<tr>
<td>GM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.36</td>
<td>$1.31</td>
<td>$1.32</td>
<td>$47.00</td>
<td>$132.0K</td>
<td>10.8K</td>
<td>2.5K</td>
</tr>
<tr>
<td>GM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.22</td>
<td>$1.1</td>
<td>$1.11</td>
<td>$30.00</td>
<td>$111.0K</td>
<td>6.9K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About General Motors</h3>
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its us market share leader crown in 2022, after losing it to Toyota due to the chip shortage in 2021. 2023's share was 16.5%. GM's Cruise autonomous vehicle arm has previously done driverless geofenced AV robotaxi services in San Francisco and other cities but stopped in late 2023 after an accident. It restarted service in 2024 but not in California. GM owns over 80% of Cruise. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
After a thorough review of the options trading surrounding General Motors, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>General Motors's Current Market Status</h3>
<ul>
<li>With a trading volume of 5,775,085, the price of GM is down by -0.73%, reaching $47.58.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 12 days from now.</li>
</ul>
<h3>What Analysts Are Saying About General Motors</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $53.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Morgan Stanley lowers its rating to Underweight with a new price target of $42. 
&#x2A; In a cautious move, an analyst from Wedbush downgraded its rating to Outperform, setting a price target of $55. 
&#x2A; An analyst from Bernstein has revised its rating downward to Market Perform, adjusting the price target to $53. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $54. 
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on General Motors, maintaining a target price of $61. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for General Motors with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

This Is What Whales Are Betting On General Motors

High-rolling investors have positioned themselves bullish on Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SNAP often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Snap. This is not a typical pattern.
The sentiment among these major traders is split, with 63% bullish and 36% bearish. Among all the options we identified, there was one put, amounting to $51,500, and 10 calls, totaling $949,490.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $5.0 to $15.0 for Snap over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Snap's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Snap's whale activity within a strike price range from $5.0 to $15.0 in the last 30 days. 
<h3>Snap 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728587021_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNAP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.07</td>
<td>$2.02</td>
<td>$2.02</td>
<td>$15.00</td>
<td>$202.1K</td>
<td>8.4K</td>
<td>1.3K</td>
</tr>
<tr>
<td>SNAP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.06</td>
<td>$2.02</td>
<td>$2.02</td>
<td>$15.00</td>
<td>$202.0K</td>
<td>8.4K</td>
<td>2.3K</td>
</tr>
<tr>
<td>SNAP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$6.75</td>
<td>$6.75</td>
<td>$6.75</td>
<td>$5.00</td>
<td>$195.7K</td>
<td>1.1K</td>
<td>650</td>
</tr>
<tr>
<td>SNAP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$3.1</td>
<td>$3.0</td>
<td>$3.1</td>
<td>$13.00</td>
<td>$89.9K</td>
<td>768</td>
<td>650</td>
</tr>
<tr>
<td>SNAP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$6.75</td>
<td>$6.65</td>
<td>$6.75</td>
<td>$5.00</td>
<td>$67.5K</td>
<td>1.1K</td>
<td>310</td>
</tr>
</tbody>
</table>

<h3>About Snap</h3>
Snap owns one of the most popular social networking apps, Snapchat, claiming more than 400 million daily active users as of the end of 2023. Snap generates nearly all its revenue from advertising. While only about one quarter of users are in North America, the region accounts for about 65% of sales.
After a thorough review of the options trading surrounding Snap, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Snap</h3>
<ul>
<li>With a trading volume of 8,749,623, the price of SNAP is down by -0.6%, reaching $10.62.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 19 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Snap</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $11.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Snap, maintaining a target price of $14. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Neutral, adjusting the price target to $8. 
&#x2A; Reflecting concerns, an analyst from B. Riley Securities lowers its rating to Neutral with a new price target of $11. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Neutral, adjusting the price target to $8. 
&#x2A; Consistent in their evaluation, an analyst from Deutsche Bank keeps a Buy rating on Snap with a target price of $14. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Snap options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

SNAP

Snap's Options: A Look at What the Big Money is Thinking

JP Morgan analyst Jimmy Bhullar maintains Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) with a Neutral and raises the price target from $108 to $110.

ACGL

JP Morgan Maintains Neutral on Arch Capital Group, Raises Price Target to $110

JP Morgan analyst Jimmy Bhullar maintains Baldwin Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWIN#NASDAQ">BWIN</a>) with a Overweight and raises the price target from $45 to $54.

BWIN

JP Morgan Maintains Overweight on Baldwin Insurance, Raises Price Target to $54

9 analysts have shared their evaluations of Hubbell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBB#NYSE">HUBB</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Hubbell, revealing an average target of $416.67, a high estimate of $454.00, and a low estimate of $368.00. This upward trend is evident, with the current average reflecting a 4.23% increase from the previous average price target of $399.75.
<img src="https://www.benzinga.com/files/images/story/2024/1728586892_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Hubbell among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$454.00</td>
<td>$385.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$445.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$400.00</td>
<td>$368.00</td>
</tr>
<tr>
<td>Chris Snyder</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$407.00</td>
<td>-</td>
</tr>
<tr>
<td>Nicole Deblase</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$441.00</td>
<td>$431.00</td>
</tr>
<tr>
<td>Tommy Moll</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$450.00</td>
<td>$450.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$368.00</td>
<td>$384.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$385.00</td>
<td>$383.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$400.00</td>
<td>$397.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Hubbell. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Hubbell compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Hubbell's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Hubbell's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HUBB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hubbell analyst ratings.</a>
<h2>Delving into Hubbell's Background</h2>
Hubbell is a diversified conglomerate industrial company that mostly competes in the electrical components market. Its products and services serve vital portions of the U.S. electrical supply chain, including transmission and distribution as well as the commercial, industrial, and residential end markets. The company organizes its business into two segments: Utility Solutions Segment and the Electrical Solutions Segment. It derives maximum revenue from Utility Solutions Segment.
<h3>Understanding the Numbers: Hubbell's Finances</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Hubbell's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 6.34%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Hubbell's net margin is impressive, surpassing industry averages. With a net margin of 14.68%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Hubbell's ROE stands out, surpassing industry averages. With an impressive ROE of 7.13%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Hubbell's ROA excels beyond industry benchmarks, reaching 3.1%. This signifies efficient management of assets and strong financial health.
Debt Management: Hubbell's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.7.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HUBB

Assessing Hubbell: Insights From 9 Financial Analysts

A2Z Cust2Mate Solutions shares are trading higher after the company announced it signed a framework agreement with Trixo for its smart cart solutions to be rolled out in Mexico and Central America.

Across the recent three months, 5 analysts have shared their insights on Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $73.4, with a high estimate of $88.00 and a low estimate of $61.00. Observing a downward trend, the current average is 6.85% lower than the prior average price target of $78.80. 
<img src="https://www.benzinga.com/files/images/story/2024/1728586884_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Root among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$64.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Yaron Kinar</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$72.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Tommy McJoynt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$61.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Thomas McJoynt-Griffith</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$80.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Root. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Root compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Root's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Root's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ROOT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Root analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Root Better</h2>
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. The company is a direct-to-consumer personal auto insurance, renters insurance and mobile technology company. It generates revenue from the sale of auto insurance policies within the United States.
<h3>Unraveling the Financial Story of Root</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Root's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 286.63%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Root's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -2.7%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Root's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -4.92%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Root's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.53%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Root's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.98, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ROOT

Analyst Scoreboard: 5 Ratings For Root

Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Hamilton Insurance Group, presenting an average target of $22.17, a high estimate of $26.00, and a low estimate of $19.00. This current average reflects an increase of 9.75% from the previous average price target of $20.20. 
<img src="https://www.benzinga.com/files/images/story/2024/1728586868_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Hamilton Insurance Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$26.00</td>
<td>-</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Tommy McJoynt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Matthew Carletti</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$25.00</td>
<td>$23.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Hamilton Insurance Group. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hamilton Insurance Group compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Hamilton Insurance Group's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Hamilton Insurance Group's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/HG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hamilton Insurance Group analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering Hamilton Insurance Group: A Closer Look</h2>
Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in Lloyd's, Ireland, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.
<h3>Understanding the Numbers: Hamilton Insurance Group's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Hamilton Insurance Group's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 62.39%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Hamilton Insurance Group's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 21.83%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Hamilton Insurance Group's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.89%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Hamilton Insurance Group's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.75% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Hamilton Insurance Group's debt-to-equity ratio is below the industry average. With a ratio of 0.07, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Hamilton Insurance Group Stock

Legal

Td Bank Says Will Undertake Balance Sheet Restructuring In Fy25; Will Reduce Assets By About 10%, Which Will Include Managing Down Or Selling Certain Loan Portfolios; Incoming CEO Says " This Is A Difficult Chapter For TD... We Will Make The Necessary Changes To Put The Bank On Stronger Foundation"

In the latest quarter, 5 analysts provided ratings for MPLX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLX#NYSE">MPLX</a>), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $48.4, along with a high estimate of $51.00 and a low estimate of $45.00. Marking an increase of 3.42%, the current average surpasses the previous average price target of $46.80. 
<img src="https://www.benzinga.com/files/images/story/2024/1728586853_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The perception of MPLX by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$49.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Brian Reynolds</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$51.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$45.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Elvira Scotto</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$47.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Michael Blum</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$50.00</td>
<td>$47.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MPLX. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of MPLX compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of MPLX's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of MPLX's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MPLX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on MPLX analyst ratings.</a>
<h2>Get to Know MPLX Better</h2>
MPLX is a partnership that owns both pipelines and gathering and processing assets with extensive holdings in the Appalachian region. The asset base is made up of pipeline assets dropped down from Marathon Petroleum, its sponsor, and gathering and processing assets from MarkWest, which it acquired in 2015. MPLX also acquired Andeavor Logistics in 2019.
<h3>MPLX's Economic Impact: An Analysis</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining MPLX's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.53% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: MPLX's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 43.63% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 8.65%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): MPLX's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.13% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: MPLX's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.67.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MPLX

Analyst Scoreboard: 5 Ratings For MPLX

Iron Mountain (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRM#NYSE">IRM</a>) has outperformed the market over the past 5 years by 15.44% on an annualized basis producing an average annual return of 29.43%. Currently, Iron Mountain has a market capitalization of $35.34 billion. 
Buying $1000 In IRM: If an investor had bought $1000 of IRM stock 5 years ago, it would be worth $3,664.31 today based on a price of $120.49 for IRM at the time of writing.
<h3>Iron Mountain's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728586841_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Iron Mountain 5 Years Ago Would Be Worth Today

Cenovus Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVE#NYSE">CVE</a>) has outperformed the market over the past 5 years by 1.84% on an annualized basis producing an average annual return of 15.83%. Currently, Cenovus Energy has a market capitalization of $32.82 billion. 
Buying $1000 In CVE: If an investor had bought $1000 of CVE stock 5 years ago, it would be worth $2,106.76 today based on a price of $17.68 for CVE at the time of writing.
<h3>Cenovus Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728586836_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today

U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO

U.S. IPO Weekly Recap: 2 SPACs Debut In Quiet Post-Holiday Week

IPO Roundup: Ardent Health, TWFG, Artiva Biotherapeutics, and more

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

IPO Roundup: Lineage, OneStream Software, and more

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into all of the biggest pre-market stock movers on Thursday morning!



Moving stocks this morning are earnings reports, a public debut, a bankruptcy filing and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) stock is rocketing more than 211% after announcing a <a href="https://www.globenewswire.com/news-release/2024/07/24/2918366/0/en/Psyence-Biomed-Announces-Export-of-Nature-Derived-Psilocybin-to-Australia-and-Provides-Update-on-Upcoming-Phase-IIb-Trial.html">psilocybin export to Australia</a> and providing a clinical trial update.</li>



<li>Tivic Health Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/tivc-stock-quote/">TIVC</a>) shares are soaring over 91% after <a href="https://www.nasdaq.com/press-release/tivic-health-expands-intellectual-property-portfolio-2024-07-23">expanding its intellectual property portfolio</a>.</li>



<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) stock is surging more than 48% <a href="https://www.wboy.com/business/press-releases/accesswire/891946/bloomz-inc-announces-pricing-of-5-38-million-initial-public-offering/">following its recent public debut</a>.</li>



<li>Cero Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cero-stock-quote/">CERO</a>) shares are rising over 32% alongside heavy pre-market trading.</li>



<li>Viking Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vktx-stock-quote/">VKTX</a>) stock is increasing more than 17% after <a href="https://www.prnewswire.com/news-releases/viking-therapeutics-reports-second-quarter-2024-financial-results-and-provides-corporate-update-302205767.html">releasing its Q2 earnings report</a>.</li>



<li>VS Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsme-stock-quote/">VSME</a>) shares are gaining close to 17% with strong early morning trading today.</li>



<li>Indivior (NASDAQ:<a href="https://investorplace.com/stock-quotes/indv-stock-quote/">INDV</a>) stock is heading over 14% higher on <a href="https://www.marketwatch.com/story/indivior-shares-jump-on-increased-revenue-100m-share-buyback-5cd4e573?mod=newsviewer_click">Q2 revenue growth</a> and a share buyback.</li>



<li>Signing Day Sports (NYSEMKT:<a href="https://investorplace.com/stock-quotes/sgn-stock-quote/">SGN</a>) shares are jumping more than 14% without any clear news this morning.</li>



<li>Davis Commodities (NASDAQ:<a href="https://investorplace.com/stock-quotes/dtck-stock-quote/">DTCK</a>) stock is getting a 14% boost on Thursday morning.</li>



<li>Stellus Capital Investment (NYSE:<a href="https://investorplace.com/stock-quotes/scm-stock-quote/">SCM</a>) shares are up over 12% despite a lack of news today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>2U (NASDAQ:<a href="https://investorplace.com/stock-quotes/twou-stock-quote/">TWOU</a>) stock is plummeting more than 68% with a <a href="https://www.nasdaq.com/press-release/2u-takes-strategic-action-significantly-strengthen-balance-sheet-and-position-company">Chapter 11 bankruptcy filing</a>.</li>



<li>Edwards Lifesciences (NYSE:<a href="https://investorplace.com/stock-quotes/ew-stock-quote/">EW</a>) shares are diving over 22% alongside <a href="https://www.nasdaq.com/press-release/edwards-lifesciences-reports-second-quarter-results-2024-07-24">lackluster Q2 results</a>.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) stock is tumbling more than 19% following a rally yesterday.</li>



<li>MaxLinear (NASDAQ:<a href="https://investorplace.com/stock-quotes/mxl-stock-quote/">MXL</a>) shares are taking an over 18% beating after <a href="https://finance.yahoo.com/news/maxlinear-inc-announces-second-quarter-200500103.html">releasing its Q2 earnings report</a>.</li>



<li>Fangdd Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/duo-stock-quote/">DUO</a>) stock is sliding more than 17% after a rally yesterday.</li>



<li>IF Bancorp (NASDAQ:<a href="https://investorplace.com/stock-quotes/iroq-stock-quote/">IROQ</a>) shares are falling over 16% despite a lack of news this morning.</li>



<li>Regencell Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgc-stock-quote/">RGC</a>) stock is dropping more than 16% <a href="https://investorplace.com/2024/07/what-is-going-on-with-regencell-bioscience-rgc-stock-today/">alongside recent volatility</a>.</li>



<li>Hoth Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/hoth-stock-quote/">HOTH</a>) shares are retreating over 15% <a href="https://investorplace.com/2024/07/why-is-hoth-therapeutics-hoth-stock-moving-today/">with recent volatility</a>.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) stock is decreasing more than 14% <a href="https://investorplace.com/2024/07/why-is-nuzee-nuze-stock-up-133-today/">after rallying yesterday</a>.</li>



<li>Dermata Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/drma-stock-quote/">DRMA</a>) shares close out our pre-market stock movers down over 14% <a href="https://investorplace.com/2024/07/why-is-dermata-therapeutics-drma-stock-up-200-today/">following a Wednesday rally</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-july-25th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!



Moving stocks this morning are earnings reports, a clinical trial update, acquisition news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Windtree Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/wint-stock-quote/">WINT</a>) stock is rocketing close to 121% <a href="https://www.nasdaq.com/press-release/windtree-therapeutics-provides-update-istaroxime-clinical-development-and-upcoming">on a clinical trial update</a>.</li>



<li>BurgerFi International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) shares are soaring more than 93% <a href="https://www.nasdaq.com/press-release/burgerfi-reaches-legal-settlement-agreement-lion-point-capital-lp-2024-07-25">on a settlement agreement</a>.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is surging over 65% on a <a href="https://www.nasdaq.com/press-release/carbon-revolution-supplies-carbon-fiber-wheels-chevrolet-corvette-zr1-2024-07-25">supply deal with Chevrolet</a>.</li>



<li>Everi (NYSE:<a href="https://investorplace.com/stock-quotes/evri-stock-quote/">EVRI</a>) shares are gaining more than 35% <a href="https://www.nasdaq.com/press-release/igts-gaming-and-digital-business-and-everi-be-acquired-simultaneously-apollo-funds">on an acquisition deal</a>.</li>



<li>Coursera (NYSE:<a href="https://investorplace.com/stock-quotes/cour-stock-quote/">COUR</a>) stock is increasing over 26% with its <a href="https://www.businesswire.com/news/home/20240725452896/en/Coursera-Reports-Second-Quarter-2024-Financial-Results">latest earnings report</a>.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) shares are rising more than 24% alongside heavy pre-market trading.</li>



<li>Selina Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/slna-stock-quote/">SLNA</a>) stock is heading over 21% higher with strong early morning trading.</li>



<li>Nova Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVA#NASDAQ">NVA</a>) shares are climbing more than 20% <a href="https://www.tipranks.com/news/company-announcements/nova-minerals-issues-millions-of-new-warrants">after issuing new warrants</a>.</li>



<li>International Game Technology (NYSE:<a href="https://investorplace.com/stock-quotes/igt-stock-quote/">IGT</a>) stock is jumping over 20% alongside the <a href="https://www.prnewswire.com/news-releases/igts-gaming-and-digital-business-and-everi-to-be-acquired-simultaneously-by-apollo-funds-in-all-cash-transaction-302207429.html">Everi acquisition news</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are up more than 17% on Friday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is crashing more than 40% without any clear news this morning.</li>



<li>DexCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/dxcm-stock-quote/">DXCM</a>) shares are plummeting over 34% on <a href="https://www.nasdaq.com/press-release/dexcom-reports-second-quarter-2024-financial-results-updates-guidance-and-announces">poor Q2 results and a cut outlook</a>.</li>



<li>Advent Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/adn-stock-quote/">ADN</a>) stock is diving more than 33% despite a lack of news this morning.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are tumbling over 30% after <a href="https://investorplace.com/2024/07/why-is-natures-miracle-nmhi-stock-up-94-today/">rallying earlier this week</a>.</li>



<li>Zynex (NASDAQ:<a href="https://investorplace.com/stock-quotes/zyxi-stock-quote/">ZYXI</a>) stock is taking a nearly 23% beating with its <a href="https://www.nasdaq.com/press-release/zynex-reports-second-quarter-2024-financial-results-2024-07-25">Q2 earnings report</a>.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) shares are sliding more than 22% <a href="https://www.nasdaq.com/press-release/ocean-power-technologies-inc-announces-fourth-quarter-and-full-year-fiscal-2024">alongside its latest earnings report</a>.</li>



<li>Renovaro (NASDAQ:<a href="https://investorplace.com/stock-quotes/renb-stock-quote/">RENB</a>) stock is dropping over 18% without any obvious news to report.</li>



<li>Avinger (NASDAQ:<a href="https://investorplace.com/stock-quotes/avgr-stock-quote/">AVGR</a>) shares are falling almost 15% this morning.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is decreasing 14% after rallying yesterday.</li>



<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares close out our pre-market stock movers down more than 13.5% after jumping yesterday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

U.S. IPO Weekly Recap: Blockbuster IPO Week Sees Nearly $6 Billion Raised, Led By Cold Storage REIT Lineage

BloomZ appoints CFO

BloomZ receives Nasdaq's non-compliance notice

ACTU

ARDT

ARTV

ATGL

AVBP

AVGR

BACQU

BIYA

BLIV

BLMZ

BTSG

CCTG

CERO

COUR

CREV

DRMA

DTCK

DTSQU

DXCM

EVRI

FATN

FLAI

HOTH

INDV

IPOS

IROQ

KSPI

KVUE

LINE

LPAAU

LPBBU

LRTX

LTMAY

LXEO

MBAVU

NIPG

NMHI

NUZE

OPTT

ORKT

PAPL

PGHL

PLTR

PYRO

QMMM

RENB

SHIM

SIMAU

SLNA

SPHAU

SUGP

TIVC

TLIH

TWFG

TWOU

VCICU

VKTX

VSME

WINT

XCUR

YIBO

ZPTA

ZYXI

IPOs

Press Releases

BloomZ Inc. Announces Closing of $5.38 Million Initial Public Offering

BloomZ Inc. Announces CFO Transition

BloomZ Announces Strategic Business Alliance with CrossVision to Create Joint Entertainment Offerings

BloomZ Announces Business Alliance with sonilude Inc. to Jointly Produce Original Animation Projects

Earnings

BloomZ Reports First Half Fiscal Year 2024 Financial and Operational Results

BloomZ Receives Nasdaq Notification Regarding Minimum Market Value of Listed Securities

BloomZ Participates in the Audio Production of The Legend of Heroes: Kai no Kiseki -Farewell, O Zemuria- Videogame

BloomZ Selected as the Primary Animation Production Contractor for an Upcoming Animation Project

Brera Holdings PLC - Class B Ordinary Shares

Brera Holdings

Cineverse

Pop Culture Group Co., Ltd - Class A Ordinary Shares

Pop Culture Gr

Dolphin Entertainment, Inc. - Common Stock

Dolphin Entertainment

Global Mofy AI Limited - Class A Ordinary Shares

Global Mofy AI

Kuke Music Holding Limited American Depositary Shares, each representing one Ordinary Share

Kuke Music Hldg

Lytus Technologies Holdings PTV. Ltd. - Common Shares

Lytus Technologies Hldgs

Moving iMage Technologies, Inc. Common Stock

Moving iMage Technologies

MultiMetaVerse Holdings Limited - Class A Ordinary Share

MultiMetaVerse Holdings

Mega Matrix

PodcastOne

Reading International Inc - Class A Non-voting Common Stock

Reading Intl

Scienjoy Holding Corporation - Class A Ordinary Shares

Scienjoy Holding

Sound Group Inc. - American Depositary Shares

Sound Group

Kartoon Studios

BloomZ shares are trading higher after the company announced it was selected as the primary animation contractor for an upcoming project.

Comments

BloomZ

뉴스

에 대한 최신 뉴스 BloomZ (NASDAQ:BLMZ) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌